http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014111790-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_66b39bb5f5695c01ef1ee63ef05b442f |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27 |
| filingDate | 2014-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71fbe938c7b3645db9ba3c71135b6d6c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_870c7f8f1d474632ceefdc6e37d0b144 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9fb881018d6b2cdb7ffe66cb45ee462 |
| publicationDate | 2014-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2014111790-A3 |
| titleOfInvention | Stable transdermal pharmaceutical drug delivery system comprising rivastigmine |
| abstract | The present invention relates to a stable transdermal pharmaceutical drug delivery system of rivastigmine or a pharmaceutically acceptable salt thereof, which is free from an antioxidant. In particularly, the present invention relates to a stable transdermal pharmaceutical drug delivery system of rivastigmine or a pharmaceutically acceptable salt thereof, which provides an enhanced absorption of drug through skin, and remains stable during a longer storage period. In addition, the present invention relates to a method of treatment of mild to moderate dementia of alzheimer's type and mild to moderate dementia of parkinson's type diseases. |
| priorityDate | 2013-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.